▮ DFV TERMINAL
--:--:-- UTC SIGN IN
F1 Terminal / LUDG

LUDG — LUDWIG ENTERPRISES, INC.

—
OTC · Health Care · Health Care Providers & Services · CIK 1960262 ·
Last close
$0.03
Market Cap
$5.04M
52W High
$0.05
52W Low
$0.02
ADV30
4,133
Next earnings
—
Ludwig Enterprises, Inc. operates as a genomic technology focused on developing testing approaches for inflammation-related chronic diseases, including cancers in the United States. The company integrates mRNA inflammatory biomarkers, proprietary machine-learning algorithms, and at-home cheek swab collection kits for cancer identification. It offers mRNA-based screening to provide early insights of potential health risks. The company develops Revealia Breast test, a non-invasive cheek swab screening kit designed to identify and analyze molecular signatures in mRNA expression associated with inflammation-related biological processes associated with the presence of breast cancer. Ludwig Enterprises, Inc. was founded in 1988 and is based in Miami, Florida.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Dec 2025 0 — -292,773 -1,077,298 247,527 0 4,635,733
Sep 2025 0 — -371,364 31,252 261,594 3,317 3,572,502
Jun 2025 0 — -585,622 -649,444 401,274 142,474 3,803,434
Mar 2025 0 0 -524,921 -540,943 252,933 16,571 3,005,649

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-644,842
Investing CF
$-8,546
Financing CF
$647,267
CapEx
$-8,546
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-9,495,799
Inventory
$4,529
Receivables
$106,000
ST Investments
—
EBIT TTM
$-1,348,235
Pretax Income TTM
$-2,236,433
Interest Exp TTM
$888,198
Analysts
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 0 -1,774,680 -2,236,433 247,527 4,635,733 — -644,842
Dec 2024 217 -1,298,189 -3,016,884 197,556 2,575,701 — -660,302
Dec 2023 0 -1,375,761 -2,456,550 112,468 1,574,033 — -647,860
Dec 2022 0 -560,505 -965,150 516,195 1,342,362 — -444,805

Peers — same industry

TickerNameMarket CapLastDaily %
BGLC BioNexus Gene Lab Corp $5.00M $2.07 —
XCRT Xcelerate, Inc. $4.28M $0.01 —
BRTX BioRestorative Therapies, Inc. $6.36M $0.25 —
ADVB Advanced Biomed Inc. $6.51M $3.98 —
HLYK HealthLynked Corp $6.91M $2.35 —

News headlines (Yahoo Finance, 1h cache)

Ludwig Enterprises Announces Publication of ASCO Abstract Detailing Novel Non-Invasive mRNA Signals that Scan for Breast Cancer
2025-05-29 13:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.
SEC EDGAR filings → · StockAnalysis.com → · OpenInsider →